Charles B. O'Keeffe, Director at CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX), bought 10,000 shares at $3.00 ($30K) on 2015-01-13, disclosed to the SEC on 2015-01-13.
Open-market purchase of $30k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CPRX | BUY | 2019-10-11 | $47K | — | Filing → |
| CPRX | BUY | 2018-12-14 | $50K | — | Filing → |
| CPRX | BUY | 2018-06-08 | $3K | — | Filing → |